chondroitin sulfate/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases WOMAC stiffness subscale
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Chondroitin sulfate used alone was also found to be effective in reducing WOMAC total score and stiffness score (P=0.038 and P=0.023, respectively).”
Quoted verbatim from Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study.. - Study
- RCT
- Duration
- 6 months
- Population
- adults with Kashin-Beck disease (KBD), chondroitin sulfate monotherapy arm, cluster-randomised trial
Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study.2012PMID:22469850Permalink
Keep reading
- Everything the graph holds on chondroitin sulfate
- Every compound studied against WOMAC stiffness subscale
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M2RCA4C4TX43A40NJPTAQ9K6